<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Example of a protocol for post-cesarean delivery pain management in hospital</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Example of a protocol for post-cesarean delivery pain management in hospital</h1>
<div class="graphic"><div class="figure"><div class="ttl">Example of a protocol for post-cesarean delivery pain management in hospital</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup> <colgroup width="70%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="2">Nonopioid analgesics for all patients</td> </tr> <tr> <td class="indent1">Acetaminophen</td> <td> <ul> <li>1 g IV intraoperative</li> </ul> plus <ul> <li>650 mg every 6 hours, or 1 g every 8 hours, orally or IV, postoperative</li> </ul> </td> </tr> <tr> <td class="indent1">NSAIDs</td> <td> <ul> <li>Ketorolac 15 to 30 mg IV intraoperative; for weight &lt;50 kg, maximum dose 15 mg</li> </ul> plus <ul> <li>Ibuprofen 600 mg every 6 hours or 800 mg every 8 hours orally, or ketorolac 15 mg IV every 6 hours for 48 to 72 hours postoperative</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="2">Patients who have neuraxial anesthesia</td> </tr> <tr> <td class="indent1">Neuraxial opioid</td> <td>Preservative-free opioid: <ul class="decimal_heading"> <li>Morphine 100 to 150 mcg intrathecal (preferred) or<br/> 3 mg epidural after delivery*</li> </ul> <ul style="list-style-type: none;"> <li>OR</li> </ul> <ul class="decimal_heading"> <li>Hydromorphone 50 to 75 mcg intrathecal or<br/> 0.4 to 1 mg epidural after delivery*</li> </ul> </td> </tr> <tr> <td class="indent1">Oral opioid</td> <td>Oxycodone 2.5 to 5 mg orally every 4 hours as needed for breakthrough pain: <ul class="decimal_heading"> <li>VNPS 1 to 4/10: 2.5 mg, repeat in 1 hour if needed<sup>¶</sup></li> <li>VNPS &gt;4/10: 5 mg, repeat in 1 hour if needed<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="2">Patients who have general anesthesia, or neuraxial anesthesia without neuraxial opioid</td> </tr> <tr> <td class="indent1">Nerve block<br/> OR<br/> Wound infiltration</td> <td>Bilateral TAP or QL block: <ul class="decimal_heading"> <li>0.25% bupivacaine 20 mL per side</li> </ul> <ul style="list-style-type: none;"> <li>OR</li> </ul> <ul class="decimal_heading"> <li>0.2% ropivacaine 20 mL per side</li> </ul> <ul style="list-style-type: none;"> <li>OR</li> </ul> <ul class="decimal_heading"> <li>Liposomal bupivacaine 1.3% 10 mL plus 0.25% aqueous bupivacaine 20 mL per side<sup>Δ</sup></li> </ul> <p class="extra_spacing_top">Wound infiltration: Subfascial (preferred) or subcutaneous wound catheter, 0.5% bupivacaine or ropivacaine 4 to 5 mL/hour</p> </td> </tr> <tr> <td class="indent1">Opioids</td> <td> <ul> <li>IV PCA with morphine or hydromorphone for up to 24 hours, transitioned to oxycodone as above by postoperative day one: <ul> <li>Morphine – demand dose 2 mg, lockout interval 10 minutes, without continuous (basal) infusion</li> <li>Hydromorphone – demand dose 0.4 mg, lockout interval 8 minutes, without continuous (basal) infusion</li> </ul> </li> </ul> OR <ul> <li>Oral oxycodone as above, with bolus IV opioids available for breakthrough pain</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="2">For severe or ongoing pain, options</td> </tr> <tr> <td class="indent1">Rescue nerve block</td> <td>Bilateral TAP or QL block as above: 0.25% bupivacaine or 0.2% ropivacaine; consider liposomal bupivacaine</td> </tr> <tr> <td class="indent1">Opioids</td> <td> <ul> <li>Fentanyl 25 to 50 mcg IV every 5 minutes, to maximum of 200 mcg until pain relief or if associated sedation, oxygen saturation &lt;95%, or serious event occurs, such as hypotension (in PACU only)</li> </ul> OR <ul> <li>Morphine 1 to 3 mg IV every 5 minutes until pain relief or if associated sedation, oxygen saturation &lt;95%, or serious event occurs, such as hypotension (in PACU only); if analgesia is insufficient after total approximately 20 mg, review overall pain control regimen</li> </ul> OR <ul> <li>Hydromorphone 0.2 to 0.5 mg IV every 5 minutes until pain relief or if associated sedation, oxygen saturation &lt;95%, or serious event occurs, such as hypotension (in PACU only); if analgesia is insufficient after approximately 3 mg, review overall pain control regimen</li> </ul> OR <ul> <li>IV PCA as above</li> </ul> </td> </tr> <tr> <td class="indent1">Nonopioid adjuncts</td> <td>Gabapentin 200 mg orally every 8 hours for 5 doses; enhanced respiratory monitoring may be necessary</td> </tr> </tbody></table></div><div class="graphic_lgnd">This protocol would be applicable for patients without particular risk factors for severe postoperative pain (eg, chronic pain, opioid tolerant). For further detail, refer to UpToDate content on post-cesarean delivery analgesia.</div><div class="graphic_footnotes"><p>IV: intravenous; NSAIDs: nonsteroidal anti-inflammatory drugs; VNPS: verbal numerical pain score; TAP: transversus abdominus plane; QL: quadratus lumborum; PCA: patient-controlled analgesia; PACU: post-anesthesia care unit.</p>
<p>* For patients who have combined spinal epidural anesthesia, intrathecal morphine is preferred, rather than epidural morphine, to minimize opioid dose and systemic absorption.</p>
<p>¶ When nursing resources are available, the use of "split-dose" opioid order sets can reduce total opioid consumption.</p>
Δ When liposomal bupivacaine is mixed with aqueous bupivacaine, the dose of bupivacaine must be &lt;50% of the dose of liposomal bupivacaine. Liposomal bupivacaine should not be mixed with other local anesthetics except for aqueous bupivacaine.</div><div id="graphicVersion">Graphic 129376 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
